# 21.06 Platform Release now live!

**URL:** <https://community.opentargets.org/t/21-06-platform-release-now-live/244>\
**Category:** Releases\
**Tags:** release-notes\
**Created:** [30 June 2021 09:38 UTC](https://community.opentargets.org/t/21-06-platform-release-now-live/244 "2021-06-30T09:38:19Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![hcornu](https://dub1.discourse-cdn.com/flex017/user_avatar/community.opentargets.org/hcornu/32/716_2.png) [@hcornu](https://community.opentargets.org/u/hcornu)\
**Post date:** [30 June 2021 09:38 UTC](https://community.opentargets.org/t/21-06-platform-release-now-live/244/1 "2021-06-30T09:38:19Z")

</div>

Just in time for the summer, we have released the latest version of the Open Targets Platform — 21.06. Thanks to the concurrent release of the Open Targets Genetics Portal, we have exciting new data from [FinnGen](https://www.finngen.fi/en), a public-private partnership to identify genotype-phenotype correlations in the Finnish population, as well as from the EBI’s [GWAS Catalog](https://www.ebi.ac.uk/gwas/). We have also ingested new target-disease associations for rare diseases from [Orphanet](https://www.orpha.net/consor/cgi-bin/index.php).

This release integrates 13,267,236 evidence strings to build 11,755,362 target-disease associations between 18,507 diseases and 60,606 targets from the following 21 public resources:

- 855,569 genetic evidence from[European Variation Archive (EVA)](http://www.ebi.ac.uk/eva/)
- 608,320 genetic evidence from[Open Targets Genetics Portal](https://genetics.opentargets.org/)
- 2,506 genetic evidence from[Gene2Phenotype](https://www.ebi.ac.uk/gene2phenotype)
- 19,322 genetic evidence from the[Genomics England PanelApp](https://bioinfo.extge.co.uk/crowdsourcing/PanelApp/)
- 1,309 genetic evidence from[ClinGen](https://search.clinicalgenome.org/kb/gene-validity/)
- 5,736 genetic evidence from Orphanet
- 183,064 genetic evidence from the[PheWAS catalog](https://phewascatalog.org/)
- 5,322 genetic evidence from[UniProt Literature](https://www.uniprot.org/)
- 11,589 somatic evidence from[European Variation Archive (EVA)](http://www.ebi.ac.uk/eva/)
- 3,141 somatic evidence from[intOGen](https://www.intogen.org/)
- 63,311 somatic evidence from the[Cancer Gene Census](http://cancer.sanger.ac.uk/census/)
- 34,001 somatic evidence from [Uniprot](http://www.uniprot.org/)
- 529,149 drug evidence from[ChEMBL](https://www.ebi.ac.uk/chembl/)
- 225,933 expression evidence from[Expression Atlas](https://www.ebi.ac.uk/gxa/home)
- 9,673 affected pathway evidence from[Reactome](https://reactome.org/)
- 72,369 affected pathway evidence from[SLAPenrich](https://saezlab.github.io/SLAPenrich/)
- 378 affected pathway evidence from[PROGENy](https://saezlab.github.io/progeny/)
- 389 systems biology evidence from[SysBio](https://saezlab.github.io/progeny/)
- 1,846 CRISPR-Cas9 (Cancer Cell Lines) evidence from[Behan et al. 2019](https://europepmc.org/abstract/MED/30971826)
- 718,250 mouse model evidence from[PhenoDigm](https://www.sanger.ac.uk/resources/databases/phenodigm)
- 9,916,059 scientific literature evidence from co-occurence mining in[Europe PMC](https://europepmc.org/)

### Key highlights for this release:

- This latest release integrates the latest data from the[Open Targets Genetics Portal](https://genetics.opentargets.org/), including data from FinnGen and full summary statistics from the GWAS Catalog;
- It also includes a new data source:[Orphanet](https://www.orpha.net/consor/cgi-bin/index.php), allowing us to feature over 700 target-disease associations unique to that dataset.

For more details, read the [21.06 release blog post](https://blog.opentargets.org/open-targets-platform-21-06-release/).